In breast cancer patients with brain metastasis, the level of CA-125 appears to be associated with both the clinical and pathological status of the individual [24], and the CA-125 level can be utilized to monitor carcinoma meningitis [36]. This evidence concerns the gene MUC16 and breast carcinoma.